Showing results (341-350 of 831) with videos related to
Sort By:
Pageof 84
Leukemia Research|August 15, 2009
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemiaJean-Marie Bruey, Hagop Kantarjian, Zeev Estrov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemiaJorge E Cortes, Dan Jones, Susan O'Brien, et al.Leukemia & Lymphoma|October 6, 2007
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathyConstantine S Tam, Susan O'Brien, Susan Lerner, et al.Cancer|September 19, 2008
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 yearsHagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.Leukemia Research|May 15, 2002
CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemiaFarhad Ravandi, Jorge Cortes, Zeev Estrov, et al.Blood|August 2, 2011
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitorsElias Jabbour, Hagop Kantarjian, Susan O'Brien, et al.Blood|August 18, 2011
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignanciesDushyant Verma, Hagop Kantarjian, Sara S Strom, et al.Leukemia Research|November 3, 2009
Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapseFarhad Ravandi, Hagop Kantarjian, Stefan Faderl, et al.The Journal of Biological Chemistry|February 23, 2008
Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cellsShinpei Nishimura, Shunsuke Takahashi, Hiromi Kamikatahira, et al.Cancer|February 8, 2017
Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinibPreetesh Jain, Philip A Thompson, Michael Keating, et al.Pageof 84